Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
Advances in Therapy|August 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.
Journal of the American Heart Association|July 17, 2026
Endotypes of Vascular Health Predict Transplantation-Free Survival in Pulmonary HypertensionSamar Farha, Bo Hu, Ruoying Chen, et al.
Antioxidants & Redox Signaling|December 10, 2024
Alterations in Mitochondrial Function in Pulmonary Vascular DiseasesSamar Farha, Kewal Asosingh, Paul M Hassoun, et al.
The Lancet. Respiratory Medicine|May 5, 2024
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trialRobert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, et al.
Journal of the American Heart Association|May 22, 2025
Dysregulated Tricarboxylic Acid Cycle Metabolism Is Associated With Right Ventricular Maladaptation in Pulmonary Vascular DiseaseDarin T Rosen, Todd M Kolb, Stephen C Mathai, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial HypertensionFranz P Rischard, Roberto J Bernardo, Rebecca R Vanderpool, et al.
Circulation. Cardiovascular Imaging|December 18, 2024
Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease from the PVDOMICS StudyMonica Mukherjee, Stephen C Mathai, Christine Jellis, et al.
Pageof 24